Hancock Jaffe Laboratories, which is developing bioprosthetic devices for cardiovascular surgeries, raised $8 million by offering an upsized 1.5 million units at $5, below $6 to $8 range. The company …
Hancock Jaffe Laboratories, which is developing bioprosthetic devices for cardiovascular surgeries, raised $8 million by offering an upsized 1.5 million units at $5, below $6 to $8 range. The company …